Getting Everyone on Board to Break the Cycle of Bacterial Vaginosis (BV) Recurrence: A Qualitative Study of Partner Treatment for BV

Overview

Journal Patient

Specialty Health Services

Date 2025 Mar 14

PMID 40085319

Authors

Alicia J King

Tiffany R Phillips

Erica L Plummer

Natasha Wild

Christopher K Fairley

Eric P F Chow

Lenka A Vodstrcil

Catriona S Bradshaw

Affiliations

Soon will be listed here.

Abstract

Introduction: Bacterial vaginosis (BV) is a common condition that affects the sexual wellbeing of women and other people with a vagina. Recurrence following individual treatment is frequent and exerts a cumulative burden over time. Researchers at the Melbourne Sexual Health Center have recently completed the first successful trial of male partner treatment (MPT) for BV, demonstrating the superior effectiveness of concurrent MPT in reducing recurrence.

Method: Using a case study design, semi-structured interviews with trial participants explored the views and experiences of nine men who had received MPT and nine women whose partners had received MPT. Action and emotion coding were employed to create an explanatory model of experiences of BV recurrence and MPT.

Results: Three key themes within this model related to the cycle of recurrent BV: the physical, psychological, and relationship impacts of BV ("experiencing BV"); the importance of healthcare providers exploring different options and understanding individual context ("seeking care"); and the frustration, cost, and inconvenience of individual treatment ("dealing with it alone"). This cycle was broken by "Getting everyone on board" with MPT. This involved women, men, and healthcare professionals understanding BV and MPT, overcoming barriers to access, and open communication between partners. These factors, in combination, resulted in couples "dealing with BV together", undertaking a week of inconvenience to share the responsibility of preventing recurrence.

Conclusion: These findings suggest that the widescale adoption of MPT for BV will require multilevel approaches to address gaps in the awareness of BV with sensitivity to the relational, social, and structural context of delivering care.

References

Peebles K, Velloza J, Balkus J, McClelland R, Barnabas R . High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sex Transm Dis. 2019; 46(5):304-311. DOI: 10.1097/OLQ.0000000000000972. View

Fredricks D, Fiedler T, Marrazzo J . Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005; 353(18):1899-911. DOI: 10.1056/NEJMoa043802. View

Ravel J, Gajer P, Abdo Z, Schneider G, Koenig S, McCulle S . Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4680-7. PMC: 3063603. DOI: 10.1073/pnas.1002611107. View

Bilardi J, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C . The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One. 2013; 8(9):e74378. PMC: 3770676. DOI: 10.1371/journal.pone.0074378. View

Fettweis J, Serrano M, Brooks J, Edwards D, Girerd P, Parikh H . The vaginal microbiome and preterm birth. Nat Med. 2019; 25(6):1012-1021. PMC: 6750801. DOI: 10.1038/s41591-019-0450-2. View

Tamarelle J, Thiebaut A, De Barbeyrac B, Bebear C, Ravel J, Delarocque-Astagneau E . The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis. Clin Microbiol Infect. 2018; 25(1):35-47. PMC: 7362580. DOI: 10.1016/j.cmi.2018.04.019. View

Waltmann A, Thomas C, Duncan J . The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections. Curr Opin Infect Dis. 2023; 36(1):35-48. PMC: 10500551. DOI: 10.1097/QCO.0000000000000893. View

Alisoltani A, Manhanzva M, Potgieter M, Balle C, Bell L, Ross E . Microbial function and genital inflammation in young South African women at high risk of HIV infection. Microbiome. 2020; 8(1):165. PMC: 7679981. DOI: 10.1186/s40168-020-00932-8. View

Atashili J, Poole C, Ndumbe P, Adimora A, Smith J . Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008; 22(12):1493-501. PMC: 2788489. DOI: 10.1097/QAD.0b013e3283021a37. View

10.

Cohen C, Lingappa J, Baeten J, Ngayo M, Spiegel C, Hong T . Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 2012; 9(6):e1001251. PMC: 3383741. DOI: 10.1371/journal.pmed.1001251. View

11.

Bradshaw C, Morton A, Hocking J, Garland S, Morris M, Moss L . High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006; 193(11):1478-86. DOI: 10.1086/503780. View

12.

Vodstrcil L, Muzny C, Plummer E, Sobel J, Bradshaw C . Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment. BMC Med. 2021; 19(1):194. PMC: 8411528. DOI: 10.1186/s12916-021-02077-3. View

13.

Bradshaw C, Vodstrcil L, Hocking J, Law M, Pirotta M, Garland S . Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis. 2012; 56(6):777-86. DOI: 10.1093/cid/cis1030. View

14.

Schwebke J, Lensing S, Lee J, Muzny C, Pontius A, Woznicki N . Treatment of Male Sexual Partners of Women With Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis. 2020; 73(3):e672-e679. PMC: 8326574. DOI: 10.1093/cid/ciaa1903. View

15.

Bilardi J, Walker S, Mooney-Somers J, Temple-Smith M, McNair R, Bellhouse C . Women's Views and Experiences of the Triggers for Onset of Bacterial Vaginosis and Exacerbating Factors Associated with Recurrence. PLoS One. 2016; 11(3):e0150272. PMC: 4773144. DOI: 10.1371/journal.pone.0150272. View

16.

Bilardi J, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Vodstrcil L . Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis. PLoS One. 2017; 12(3):e0173637. PMC: 5344463. DOI: 10.1371/journal.pone.0173637. View

17.

Vodstrcil L, Plummer E, Doyle M, Fairley C, McGuiness C, Bateson D . Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence. BMC Infect Dis. 2020; 20(1):834. PMC: 7661182. DOI: 10.1186/s12879-020-05563-w. View

18.

Wigan R, Vaughn C, Vodstrcil L, Doyle M, Kaiser M, McGuiness C . "It's just an issue and you deal with it… you just deal with it, you move on and you do it together.": Men's experiences of bacterial vaginosis and the acceptability of male partner treatment. PLoS One. 2020; 15(6):e0235286. PMC: 7323956. DOI: 10.1371/journal.pone.0235286. View

19.

Phillippi J, Lauderdale J . A Guide to Field Notes for Qualitative Research: Context and Conversation. Qual Health Res. 2018; 28(3):381-388. DOI: 10.1177/1049732317697102. View

20.

Eren A, Zozaya M, Taylor C, Dowd S, Martin D, Ferris M . Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One. 2011; 6(10):e26732. PMC: 3201972. DOI: 10.1371/journal.pone.0026732. View